EUVIMEDEUVIMED entdecken
Fallbericht

Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report

Chinese Journal of Dermatology · 14.08.2026

DOI: 10.35541/cjd.20230532 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Chinese Journal of Dermatology, online erschienen am 14.08.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report. Chinese Journal of Dermatology. https://doi.org/10.35541/cjd.20230532

Vancouver

Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report. Chinese Journal of Dermatology. 2026. doi:10.35541/cjd.20230532

BibTeX
@article{euvimed2026,
  title = {Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report},
  journal = {Chinese Journal of Dermatology},
  year = {2026},
  doi = {10.35541/cjd.20230532}
}
Kostenlos starten →